Wang, Hong <br/><br/>
Incidence, risk factors, and clinical significance of Epstein-Barr virus reactivation in myelodysplastic syndrome after allogeneic haematopoietic stem cell transplantation.  [electronic resource] 

 -  Annals of hematology  Apr 2019 
 - 987-996 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1432-0584 
<br/><br/><label>Standard No.: </label>10.1007/s00277-019-03603-3  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Allografts<br/>Child<br/>Disease-Free Survival<br/>Epstein-Barr Virus Infections--etiology<br/>Female<br/>Hematopoietic Stem Cell Transplantation<br/>Herpesvirus 4, Human<br/>Humans<br/>Incidence<br/>Male<br/>Middle Aged<br/>Myelodysplastic Syndromes--mortality<br/>Risk Factors<br/>Rituximab--administration & dosage<br/>Survival Rate<br/>Time Factors